Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disorder associated with extracellular amyloid-β peptide deposition and progressive neuron loss. Strong evidence supports that neuroinflammatory changes such as the activation of astrocytes and microglia cells are important in the disease p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Res Ther
Autors principals: Aichholzer, Freyja, Klafki, Hans-Wolfgang, Ogorek, Isabella, Vogelgsang, Jonathan, Wiltfang, Jens, Scherbaum, Norbert, Weggen, Sascha, Wirths, Oliver
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097817/
https://ncbi.nlm.nih.gov/pubmed/33947460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00828-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars